Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF 3.515
-0.095 (-2.63%)
Apr 2, 2026, 5:30 PM CET
Idorsia Market Cap
Idorsia has a market cap or net worth of 884.05 million as of April 2, 2026. Its market cap has increased by 286.52% in one year.
Market Cap
884.05M
Enterprise Value
2.06B
Revenue
220.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.52
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 884.05M, a decrease of -45.63%. That is a compound annual growth rate of -6.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 907.94M | -14.57% |
| Dec 30, 2025 | 1.06B | 586.49% |
| Dec 30, 2024 | 154.81M | -58.92% |
| Dec 29, 2023 | 376.84M | -84.18% |
| Dec 30, 2022 | 2.38B | -27.77% |
| Dec 30, 2021 | 3.30B | -22.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Basilea Pharmaceutica AG | 646.54M |
| Newron Pharmaceuticals | 308.17M |
| Santhera Pharmaceuticals Holding AG | 211.40M |
| BioVersys AG | 175.44M |
| Molecular Partners AG | 121.40M |
| Xlife Sciences AG | 118.24M |
| EvoNext Holdings | 5.91M |
| Addex Therapeutics | 4.66M |